Attis Industries, Inc., a technology company, focuses on biomass innovation and healthcare technologies. The company operates in two divisions, Technologies and Innovation. The Technology division focuses on providing patient care services; diagnostic and therapeutic solutions for patients and healthcare providers; and products and services in various areas, including hospital consulting services for laboratory and emergency department, polymerase chain reaction molecular testing, pharmacogenetics testing, and medication therapy management. This division also offers Bright City, a mobile application that enables towns, cities, and municipalities to communicate directly. The Innovation division focuses on producing materials and fuels from renewable sources. The company was formerly known as Meridian Waste Solutions, Inc. and changed its name to Attis Industries, Inc. in April 2018. Attis Industries, Inc. was incorporated in 1993 and is headquartered in Milton, Georgia....
+See More2019-07-11 10:48:00 Thursday ET
France and Germany are the biggest beneficiaries of Sino-U.S. trade escalation, whereas, Japan, South Korea, and Taiwan suffer from the current trade stando
2018-07-15 11:35:00 Sunday ET
Facebook, Google, and Twitter attend a U.S. House testimony on whether these social media titans filter web content for political reasons. These network pla
2025-06-21 10:25:00 Saturday ET
Former New York Times science author and Harvard psychologist Daniel Goleman explains why emotional intelligence can serve as a more important critical succ
2028-01-31 11:29:00 Monday ET
Today, the major passive index funds, private equity titans, hedge funds, and exchange funds etc combine to reshape Wall Street and several other global fin
2020-11-17 08:27:00 Tuesday ET
Management consultants can build sustainable trust-driven client relations through the accelerant curve of business value creation. Alan Weiss (2016)
2019-05-01 09:27:00 Wednesday ET
Apple settles its 2-year intellectual property lawsuit with Qualcomm by agreeing to a multi-year patent license with royalty payments to the microchip maker